KPV Made in USA — Third-Party Verified
KPV (Lysine-Proline-Valine) is an anti-inflammatory tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH), widely investigated for its ability to modulate inflammatory signaling pathways in epithelial and immune cell lines. PX1 Research supplies high-purity, USA-synthesized KPV peptide manufactured under strict GMP-compliant protocols and independently tested by ISO 17025 accredited laboratories. Designed exclusively for in vitro and preclinical research applications, every lot includes comprehensive HPLC and mass spectrometry verification.
Quick answer
KPV (Lysine-Proline-Valine) is an anti-inflammatory tripeptide derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH), widely investigated for its ability to modulate inflammatory signaling pathways in epithelial and immune cell lines. PX1 Research supplies high-purity, USA-synthesized KPV peptide manufactured under strict GMP-compliant protocols and independently tested by ISO 17025 accredited laboratories. Designed exclusively for in vitro and preclinical research applications, every lot includes comprehensive HPLC and mass spectrometry verification.
Key takeaways
- [KPV](/research-peptides/kpv) is a tripeptide composed of the amino acid sequence Lysine-Proline-Valine.
- The primary mechanism of action characterized for [KPV](/research-peptides/kpv) centers on the inhibition of nuclear factor kappa B (NF-kB), a pivotal transcription factor regulating pro-inflammatory gene expression.
- A major domain of preclinical interest for [KPV](/research-peptides/kpv) involves its protective role in intestinal epithelial barrier function.
- The analytical reliability of peptide research depends entirely on the chemical purity and structural integrity of the synthesized compound.
Molecular Structure and Biochemical Origins of KPV
KPV is a tripeptide composed of the amino acid sequence Lysine-Proline-Valine. It corresponds to amino acid residues 11 through 13 located at the C-terminus of the naturally occurring peptide hormone alpha-MSH. While full-length alpha-MSH exerts systemic endocrine effects via binding to multiple melanocortin receptors (MC1R through MC5R), the truncated KPV fragment retains potent anti-inflammatory properties while exhibiting distinct receptor-binding profiles and reduced pigmentary activation.
In chemical structure assays, KPV demonstrates a low molecular weight (approximately 341.42 g/mol), allowing for efficient intracellular uptake and interaction with cytoplasmic target proteins. Preclinical studies suggest that the biological activity of KPV relies heavily on its unique secondary conformation, where the central proline residue induces a turn that facilitates optimal interaction with intracellular signaling complexes. Research laboratories investigating anti-inflammatory peptides frequently utilize KPV to isolate localized cellular signaling events without triggering broad systemic receptor cascades.
Intracellular Mechanisms and Inflammatory Pathway Modulation
The primary mechanism of action characterized for KPV centers on the inhibition of nuclear factor kappa B (NF-kB), a pivotal transcription factor regulating pro-inflammatory gene expression. In vitro data indicate that KPV directly translocates across cellular membranes to interact with cytoplasmic elements of the NF-kB pathway. Rather than acting primarily through surface-bound melanocortin receptors, KPV enters enterocytes and immune cells where it attenuates the phosphorylation and degradation of IkB-alpha, thereby blocking the nuclear translocation of p65/p50 NF-kB subunits.
By inhibiting NF-kB activation, experimental models demonstrate that KPV reduces the transcription of key pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1beta), and interleukin-6 (IL-6). Furthermore, preclinical assays show that KPV suppresses inducible nitric oxide synthase (iNOS) expression and limits reactive oxygen species (ROS) production in stimulated macrophages. Researchers investigating kpv peptide research prioritize this targeted intracellular pathway to evaluate down-stream gene expression profiles in inflamed tissue explants.
Investigational Focus: Intestinal Barrier Integrity and Colitis Models
A major domain of preclinical interest for KPV involves its protective role in intestinal epithelial barrier function. The intestinal epithelium relies on specialized tight junction complexes—including zonula occludens-1 (ZO-1), occludin, and claudins—to maintain selective permeability and prevent pathogen translocation. In vitro assays using Caco-2 and HT-29 enterocyte monolayers demonstrate that exposure to KPV preserves transepithelial electrical resistance (TEER) under cytokine-induced stress.
In vivo rodent models of inflammatory bowel disease (IBD), such as dextran sulfate sodium (DSS)-induced colitis and trinitrobenzene sulfonic acid (TNBS)-induced colitis, provide further insights into KPV function. Preclinical studies suggest that administration of KPV attenuates histological damage, preserves mucosal crypt architecture, and significantly reduces myeloperoxidase (MPO) activity in colonic tissue samples. These findings establish KPV as a primary reference compound for evaluating targeted mucosal therapies in gastrointestinal research.
The Strategic Importance of Sourcing USA-Synthesized KPV
The analytical reliability of peptide research depends entirely on the chemical purity and structural integrity of the synthesized compound. Sourcing KPV made in USA ensures adherence to rigorous manufacturing standards that eliminate common sources of experimental variability. Overseas synthesis facilities often utilize lower-grade reagents or incomplete purification steps, leading to high levels of residual trifluoroacetic acid (TFA), counterion contamination, or truncated amino acid impurities that skew cell culture viability assays.
PX1 Research maintains complete domestic production of its research peptides. Utilizing solid-phase peptide synthesis (SPPS) within GMP-compliant USA facilities, every step—from amino acid coupling to final cleavage and lyophilization—is closely monitored. Domestic synthesis ensures strict control over residual solvent limits, chiral purity, and heavy metal presence, providing academic and pharmaceutical investigators with reproducible chemical tools for advanced laboratory research use.
Third-Party Verification: ISO 17025 HPLC, MS, and Endotoxin Testing
To guarantee uncompromising quality, PX1 Research submits every production lot of KPV to independent ISO 17025 accredited testing laboratories. Validation is not performed in-house; instead, unbiased third-party analytical reports are generated per lot and made accessible directly to researchers. Quality assurance protocols for KPV encompass three essential analytical metrics:
1. High-Performance Liquid Chromatography (HPLC): Confirms chemical purity levels exceeding 98.0%, ensuring that chromatographic peaks reflect a singular, homogenous peptide species without significant degradation products. 2. Electrospray Ionization Mass Spectrometry (ESI-MS): Verifies exact molecular mass, confirming the precise molecular weight and primary sequence identity of the Lys-Pro-Val tripeptide. 3. Limulus Amebocyte Lysate (LAL) Endotoxin Testing: Measures bacterial endotoxin levels to ensure values remain below strict threshold limits (<0.05 EU/mg), preventing artifactual immune activation during sensitive cell culture or animal model studies.
Comparative Analysis: KPV vs. Related Mucosal and Anti-Inflammatory Peptides
When designing preclinical protocols for mucosal repair or inflammatory modulation, researchers often compare KPV against other established investigational peptides. Understanding the functional differences between these molecules allows for precise selection based on the targeted pathway.
While KPV functions primarily via intracellular NF-kB suppression and localized cytokine inhibition, peptides like BPC-157 target growth factor signaling, angiogenesis, and focal adhesion kinase pathways to promote structural tissue repair. Alternatively, compounds like Larazotide act specifically as tight junction regulators by inhibiting zonulin receptors on the luminal membrane, without directly altering intracellular cytokine transcription. Additionally, antimicrobial research peptides such as LL-37 combine immunomodulatory properties with direct membrane-disrupting antimicrobial activity, whereas KPV focuses strictly on modulating inflammatory gene transcription. Utilizing these distinct peptides in comparative assays provides a comprehensive mapping of epithelial tissue defense mechanisms.
Laboratory Reconstitution, Handling, and Storage Standards
Proper handling and reconstitution protocols are vital to preserve the stability and bioactivity of lyophilized KPV in laboratory settings. Lyophilized KPV powder should be stored at -20°C or -80°C upon receipt, protected from moisture and direct light. Under these conditions, the desiccated tripeptide maintains stability for extended periods.
For reconstitution, investigators should allow the vial to equilibrate to room temperature prior to adding solvent to prevent condensation inside the container. KPV is highly soluble in sterile, deionized water or phosphate-buffered saline (PBS, pH 7.4). For sensitive cell culture applications, stock solutions should be prepared using sterile-filtered solvents under a laminar flow hood. Once reconstituted, liquid solutions should be aliquoted into single-use polypropylene tubes and stored at -80°C to avoid repeated freeze-thaw cycles, which can degrade peptide integrity. Comprehensive testing guidelines can be found in our analytical testing hub.
Preclinical Application Protocols and In Vitro Assay Design
In vitro experimental designs using KPV typically evaluate direct cellular responses in epithelial monolayers, macrophage cultures, or primary immune cell suspensions. Standard concentrations tested in published literature range from 10^-10 M to 10^-6 M depending on the specific cell line and stimulus applied. Researchers frequently measure parameters such as NF-kB p65 nuclear translocation using immunofluorescence or Western blot analysis following stimulation with lipopolysaccharide (LPS) or TNF-alpha.
For barrier function assays, Caco-2 cells are seeded onto Transwell permeable supports and allowed to differentiate into polarized monolayers. TEER values are monitored using volt-ohmmeters before and after inflammatory challenge in the presence or absence of KPV. Furthermore, permeation assays using FITC-dextran marker flux provide quantitative measurement of paracellular pathway permeability. All protocols utilizing KPV must be designed exclusively for in vitro or preclinical animal research models.
Institutional Procurement and Custom Synthesis Capabilities
PX1 Research supports university research departments, biotechnology firms, and institutional laboratories with reliable procurement pathways for USA-synthesized peptides. We offer standard research quantities as well as bulk manufacturing options tailored to large-scale study requirements. Institutional clients benefit from dedicated account coordination, lot preservation for longitudinal studies, and complete batch documentation.
Orders placed before standard cutoff times ship same-day, Monday through Friday, directly from our domestic distribution hubs in California and Arizona. Through our streamlined wholesale program, research organizations can establish automated reordering schedules and access custom synthesis options including specific salt conversions (e.g., acetate vs. TFA exchange) or specialized isotope labeling for advanced mass spectrometry analysis.
Frequently Asked Questions
What is KPV and what is its molecular origin?
KPV is an anti-inflammatory tripeptide consisting of Lysine-Proline-Valine. It represents the C-terminal sequence (residues 11–13) of alpha-melanocyte-stimulating hormone (alpha-MSH) and is studied for its ability to modulate intracellular inflammatory signaling without inducing melanogenic pathways.
Why is USA synthesis critical for KPV peptide research?
USA synthesis ensures strict adherence to GMP manufacturing standards, precise amino acid sequence coupling, and effective removal of harmful reaction byproducts like residual TFA. Domestic production eliminates international supply chain delays and guarantees consistent batch-to-batch chemical properties.
How does PX1 Research verify the purity of KPV?
Every lot of KPV undergoes third-party testing at an independent ISO 17025 accredited laboratory. Purity is verified to exceed 98% via High-Performance Liquid Chromatography (HPLC), mass identity is confirmed via ESI-MS, and endotoxin levels are measured using LAL assays.
What endotoxin levels are acceptable for KPV in cell culture studies?
PX1 Research enforces a strict endotoxin limit of less than 0.05 EU/mg for KPV. Low endotoxin levels are essential in preclinical research to ensure that observed cellular responses are due to the peptide itself and not artifactual activation caused by bacterial lipopolysaccharides.
How should lyophilized KPV be stored upon receipt?
Lyophilized KPV powder should be stored at -20°C or -80°C in a dry environment protected from light. Properly stored desiccated peptide remains stable for prolonged periods.
What solvents are recommended for reconstituting KPV?
KPV readily dissolves in sterile deionized water or phosphate-buffered saline (PBS, pH 7.4). Solvents should be sterile-filtered prior to use in cell culture assays to maintain sterility.
How does KPV differ from full-length alpha-MSH in preclinical studies?
Unlike full-length alpha-MSH, which acts via cell-surface melanocortin receptors (MC1R-MC5R) to trigger systemic endocrine and pigmentary responses, KPV acts primarily by entering cells and directly inhibiting intracellular NF-kB inflammatory cascades.
Can PX1 Research supply KPV in bulk quantities for institutional laboratories?
Yes, PX1 Research offers institutional supply, lot reservation, and bulk custom synthesis options through our wholesale laboratory account services. All orders ship directly from our facilities in CA and AZ.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.